Modified Glycine Precipitation Technique for the Preparation of Factor VIII Concentrate of High Purity and High Stability
- 5 March 1987
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 52 (1-2) , 10-14
- https://doi.org/10.1111/j.1423-0410.1987.tb02980.x
Abstract
A modification of the glycine precipitation method for the production of factor VIII concentrate is reported. In this procedure, cryoprecipitate was prepared, washed and dissolved in buffer. Contaminating fibrinogen was precipitated by the addition of 2.8 M glycine buffer at 30.degree.C.The fibrinogen precipitate was removed by filtration using a layer of glass beads. Factor VIII was then precipitated from the filtrate by adding solid NaCl. After centrifugation, the precipitate was resuspended in buffer, desalted, sterilized by filtration, lyophilized and subjected to dry-heat treatment. The procedure gave a good recovery of factor VIII (280 IU/l) and seems applicable to large-scale production. The resulting factor VIII concentrate was especially characterized by its high purity (10 IU/mg) and stabiity both in the liquid state and during dry-heat treatment.This publication has 10 references indexed in Scilit:
- Purification of the factor VIII complexThrombosis Research, 1984
- Enhanced Yield of Antihemophilic Factor and von Willebrand Factor by Cryoprecipitation with Polyethylene Glycol1Vox Sanguinis, 1979
- A Therapeutic Concentrate of Coagulation Factors II, IX and X from Citrated, Factor VIII‐Depleted PlasmaVox Sanguinis, 1973
- Methods for the Production of Clinically Effective Intermediate and High-Purity Factor-VIII ConcentratesBritish Journal of Haematology, 1971
- v. Willebrand's Disease in Sweden.Acta Medica Scandinavica, 1959
- Experiments on a new Clotting Factor (Factor VII)Acta Haematologica, 1951
- Physiology and Pathology of Blood CoagulationActa Haematologica, 1951
- DETERMINATION OF SERUM PROTEINS BY MEANS OF THE BIURET REACTIONJournal of Biological Chemistry, 1949